{"nct_id":"NCT04272203","title":"A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers","status":"TERMINATED","status_verified_date":"2022-09","start_date":"2020-05-05","start_date_type":"ACTUAL","primary_completion_date":"2022-06-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}